Acute retinal arterial occlusion after intravenous administration of bevacizumab<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Bevacizumab is known to cause retinal artery occlusion when given by intravitreal injection. However, in this case, the authors describe retinal artery occlusion with bevacizumab given systemically. Acute retinal arterial occlusion after intravenous administration of bevacizumab […]<\/p>\n
Read More…<\/a><\/p>\n","protected":false},"author":132,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[203],"tags":[],"class_list":["post-107","post","type-post","status-publish","format-standard","hentry","category-editors-choice"],"yoast_head":"\nAcute retinal arterial occlusion after intravenous administration of bevacizumab - BMJ Case Reports blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/case-reports\/2010\/06\/03\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acute retinal arterial occlusion after intravenous administration of bevacizumab - BMJ Case Reports blog\" \/>\n<meta property=\"og:description\" content=\"Bevacizumab is known to cause retinal artery occlusion when given by intravitreal injection. However, in this case, the authors describe retinal artery occlusion with bevacizumab given systemically. Acute retinal arterial occlusion after intravenous administration of bevacizumab [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/case-reports\/2010\/06\/03\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\/\" \/>\n<meta property=\"og:site_name\" content=\"BMJ Case Reports blog\" \/>\n<meta property=\"article:published_time\" content=\"2010-06-03T15:03:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2010-06-15T12:28:37+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2010\\\/06\\\/03\\\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2010\\\/06\\\/03\\\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Acute retinal arterial occlusion after intravenous administration of bevacizumab\",\"datePublished\":\"2010-06-03T15:03:28+00:00\",\"dateModified\":\"2010-06-15T12:28:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2010\\\/06\\\/03\\\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\\\/\"},\"wordCount\":45,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#organization\"},\"articleSection\":[\"Editors choice\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2010\\\/06\\\/03\\\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2010\\\/06\\\/03\\\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2010\\\/06\\\/03\\\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\\\/\",\"name\":\"Acute retinal arterial occlusion after intravenous administration of bevacizumab - BMJ Case Reports blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#website\"},\"datePublished\":\"2010-06-03T15:03:28+00:00\",\"dateModified\":\"2010-06-15T12:28:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2010\\\/06\\\/03\\\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2010\\\/06\\\/03\\\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2010\\\/06\\\/03\\\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acute retinal arterial occlusion after intravenous administration of bevacizumab\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/\",\"name\":\"BMJ Case Reports blog\",\"description\":\"The official BMJ Case Reports blog, a place to discuss wider medical progress and implications.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#organization\",\"name\":\"BMJ Case Reports blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/files\\\/2017\\\/10\\\/blog-logo-case-reports.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/files\\\/2017\\\/10\\\/blog-logo-case-reports.png\",\"width\":224,\"height\":34,\"caption\":\"BMJ Case Reports blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/author\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acute retinal arterial occlusion after intravenous administration of bevacizumab - BMJ Case Reports blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/case-reports\/2010\/06\/03\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\/","og_locale":"en_US","og_type":"article","og_title":"Acute retinal arterial occlusion after intravenous administration of bevacizumab - BMJ Case Reports blog","og_description":"Bevacizumab is known to cause retinal artery occlusion when given by intravitreal injection. However, in this case, the authors describe retinal artery occlusion with bevacizumab given systemically. Acute retinal arterial occlusion after intravenous administration of bevacizumab [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/case-reports\/2010\/06\/03\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\/","og_site_name":"BMJ Case Reports blog","article_published_time":"2010-06-03T15:03:28+00:00","article_modified_time":"2010-06-15T12:28:37+00:00","twitter_card":"summary_large_image","twitter_misc":{"Written by":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/case-reports\/2010\/06\/03\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/2010\/06\/03\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\/"},"author":{"name":"","@id":""},"headline":"Acute retinal arterial occlusion after intravenous administration of bevacizumab","datePublished":"2010-06-03T15:03:28+00:00","dateModified":"2010-06-15T12:28:37+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/2010\/06\/03\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\/"},"wordCount":45,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/#organization"},"articleSection":["Editors choice"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/case-reports\/2010\/06\/03\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/case-reports\/2010\/06\/03\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\/","url":"https:\/\/blogs.bmj.com\/case-reports\/2010\/06\/03\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\/","name":"Acute retinal arterial occlusion after intravenous administration of bevacizumab - BMJ Case Reports blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/#website"},"datePublished":"2010-06-03T15:03:28+00:00","dateModified":"2010-06-15T12:28:37+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/2010\/06\/03\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/case-reports\/2010\/06\/03\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/case-reports\/2010\/06\/03\/acute-retinal-arterial-occlusion-after-intravenous-administration-of-bevacizumab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/case-reports\/"},{"@type":"ListItem","position":2,"name":"Acute retinal arterial occlusion after intravenous administration of bevacizumab"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/case-reports\/#website","url":"https:\/\/blogs.bmj.com\/case-reports\/","name":"BMJ Case Reports blog","description":"The official BMJ Case Reports blog, a place to discuss wider medical progress and implications.","publisher":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/case-reports\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/case-reports\/#organization","name":"BMJ Case Reports blog","url":"https:\/\/blogs.bmj.com\/case-reports\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/case-reports\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/case-reports\/files\/2017\/10\/blog-logo-case-reports.png","contentUrl":"https:\/\/blogs.bmj.com\/case-reports\/files\/2017\/10\/blog-logo-case-reports.png","width":224,"height":34,"caption":"BMJ Case Reports blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"","url":"https:\/\/blogs.bmj.com\/case-reports\/author\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/posts\/107","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/users\/132"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/comments?post=107"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/posts\/107\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/media?parent=107"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/categories?post=107"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/tags?post=107"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}